Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.52 |
| ▸ | KDR | P35968 | 4/20 | 0.50 |
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.48 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26548713 | 0.96 | CYP11B2 (0.51) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26549224 | 0.92 | CYP2A6 (0.50) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548199 | 0.91 | CYP11B2 (0.54) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548403 | 0.89 | CYP11B2 (0.61) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26547979 | 0.89 | CYP11B2 (0.61) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548711 | 0.87 | CYP11B2 (0.52) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548208 | 0.85 | S1PR1 (0.45) | CYP11B2CYP11B1KDREGFRFGFR1 | |
| SCHEMBL26548901 | 0.85 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548587 | 0.85 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548179 | 0.84 | CYP11B1 (0.43) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | CYP11B2 1913/4885CYP11B1 1676/4885CYP19A1 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.